FDA Clears First Blood Test to Reliably Predict Alzheimer’s Disease

The US Just Approved The First Blood Test For Alzheimer's Disease

The United States on Friday approved the first blood test for Alzheimer's, a move that could help patients begin treatment earlier with newly approved drugs that slow the progression of the devastating neurological disease.

FDA endorses first-of-its-kind blood test for Alzheimer’s disease

The Food and Drug Administration on Friday green-lit a blood test to detect plaques in the brain associated with Alzheimer’s disease, providing a less risky and more accessible tool to help diagnose the neurodegenerative condition.

US approves first Alzheimer’s blood test

The NewsThe US Food and Drug Administration approved the first blood test to help diagnose Alzheimer’s disease, a move that could make it easier to detect the condition early in some people.The test, developed by a Japanese biotech company, looks for proteins in the blood that can indicate the presence of amyloid plaques in the brain — a key hallmark of Alzheimer’s. The blood test can’t definitively diagnose the disease, for which there is also …

FDA clears first blood test for Alzheimer's disease

The FDA has approved the first blood test for Alzheimer's disease based on a blood test – from Fujirebio – in a step forward for early diagnosis

Market 32/Price Chopper partners with Freihofer's to support Alzheimer's Association

SCHENECTADY, N.Y. (NEWS10) -- Market 32/Price Chopper has partnered with Freihofer's Baking Company to raise money in support of the Alzheimer's Association. Funds will go towards disease detection and treatment efforts. Get the latest news, weather, sports and entertainment delivered right to your inbox! Throughout the months of May and June, the grocery store will donate 10 cents to the Alzheimer's Association with each purchase of speci…

The FDA Just Approved an Alzheimer's Disease Blood Test

If you or someone you love is concerned about Alzheimer’s disease, the process of detecting its presence can involve a series of tests. As the Mayo Clinic’s history of the process reminds us, this is a step forward from the previous method of testing, which could only be accomplished posthumously. Based on a recent decision from the FDA, however, the process of diagnosing Alzheimer’s disease could become a lot more efficient.This week, the FDA a…